/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA) (Kazia or the company) received a letter on May 22, 2024 from Nasdaq notifying the Company that,.
BioXcel Therapeutics (NASDAQ:BTAI – Get Free Report) and Kazia Therapeutics (NASDAQ:KZIA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, earnings, profitability and analyst recommendations. Volatility and Risk BioXcel Therapeutics has a […]
Kazia Therapeutics (NASDAQ:KZIA) versus BioXcel Therapeutics (NASDAQ:BTAI) Head to Head Comparison theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that the Safety Review Team.